VKTX Stock Loses Over $1B in a Month: How to Play …

Viking Therapeutics, Inc. (VKTX) interactive stock chart - Yahoo FinanceViking Therapeutics, Inc. (VKTX) stock price, news, quote and history ...

$1
OFF

VKTX Stock Loses Over $1B In A Month: How To Play …

2 weeks from now

Viking Therapeutics, Inc. (VKTX) interactive stock chart - Yahoo FinanceViking Therapeutics, Inc. (VKTX) stock price, news, quote and history ...

yahoo.com

17%
OFF

VKTX Stock Loses Over $1B In A Month: How To Play The Stock?

2 weeks from now

Nov 22, 2024 · Shares of Viking Therapeutics VKTX have lost nearly 17% in the past month, translating to about $1.2 billion in market value, compared with the industry’s 7.1% decline.The …

tradingview.com

20%
OFF

VKTX Stock Loses More Than 20% In Six Months: Should You Buy …

2 weeks from now

Shares of Viking Therapeutics VKTX have lost nearly 22% in the past six months, significantly underperforming the industry’s 5.3% decline. The stock also underperformed the broader …

msn.com

$1
OFF

All News For VKTX : Viking Therapeutics - Zacks.com

2 weeks from now

Dec 9, 2024 · How to Play LLY Stock as Zepbound Beats NVO's Wegovy in Obesity Study. by Kinjel Shah Published on December 06,2024 . ... VKTX Stock Loses Over $1B in a Month: …

zacks.com

20%
OFF

VKTX Stock Loses More Than 20% In Six Months: Should You Buy …

2 weeks from now

Jan 2, 2025 · VKTX Stock Valuation & Estimates The company is trading at a premium to the industry. Going by the price/book ratio, the stock currently trades at 4.92, trailing 12-month …

nasdaq.com

09%
OFF

Viking Therapeutics, Inc. (VKTX) Stock Sinks As Market Gains

2 weeks from now

1 day ago · In the latest market close, Viking Therapeutics, Inc. (VKTX) reached $38.88, with a -1.09% movement compared to the previous day. The stock's change was less than the S&P …

nasdaq.com

20%
OFF

VKTX Stock Loses More Than 20% In Six Months: Should You Buy …

2 weeks from now

Jan 2, 2025 · Shares of Viking Therapeutics VKTX have lost nearly 22% in the past six months, significantly underperforming the industry’s 5.3% decline. The stock also underperformed the …

tradingview.com

24%
OFF

Why Viking Therapeutics Stock Plummeted By 24% In December

2 weeks from now

Jan 4, 2025 · The stakes are high in the weight-loss game. With only two GLP-1 drugs approved specifically for weight loss in the U.S., the market is still wide open.

fool.com

$1
OFF

Viking Therapeutics, Inc. (VKTX) Stock Price, News, Quote And …

2 weeks from now

VKTX Stock Loses Over $1B in a Month: How to Play the Stock? Zacks • 10 days ago Do Redditors Think That Viking Therapeutics Inc. (VKTX) Has a Big Upside Potential?

yahoo.com

75%
OFF

VKTX Keystats — Stockrow

2 weeks from now

Apr 1, 2015 · Viking Therapeutics, Inc. (VKTX) stock dropped by 1.75% to $47.03, while the Dow fell by 0.2% and Nasdaq increased by 0.12%. ... VKTX Stock Loses Over $1B in a Month: …

stockrow.com

20%
OFF

VKTX Stock Loses More Than 20% In Six Months: Should You Buy …

2 weeks from now

Jan 2, 2025 · Shares of Viking Therapeutics (VKTX Quick Quote VKTX - Free Report) have lost nearly 22% in the past six months, significantly underperforming the industry’s 5.3% decline. …

zacks.com

$1
OFF

Viking Therapeutics Inc (VKTX) Live Stock Price, Forecast & News

2 weeks from now

Nov 27, 2024 · View Viking Therapeutics Inc (VKTX) stock price today, market news, streaming charts, forecasts and financial information from FX Empire. ... VKTX Stock Loses Over $1B in …

fxempire.com

25%
OFF

Viking Therapeutics (VKTX) Market Cap - Zacks.com

2 weeks from now

Novo Nordisk Plunges 25% in 3 Months: How to Play the Stock 11/22/24-10:28AM EST Zacks VKTX Stock Loses Over $1B in a Month: How to Play the Stock? 11/22/24-8:18AM EST Zacks.

zacks.com

83%
OFF

Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market

2 weeks from now

Dec 20, 2024 · The most recent trading session ended with Viking Therapeutics, Inc. (VKTX) standing at $42.25, reflecting a +1.83% shift from the previouse trading day's closing. The …

tradingview.com

29%
OFF

Viking Stock Rises 29% In Three Months: Time To Buy, Hold Or …

2 weeks from now

Oct 18, 2024 · Shares of Viking Therapeutics VKTX have risen 29% in the past three months, significantly outperforming the industry’s 2.5% growth. The stock has outperformed the sector …

nasdaq.com

29%
OFF

Viking Stock Rises 29% In Three Months: Time To Buy, Hold Or Sell?

2 weeks from now

Oct 18, 2024 · Shares of Viking Therapeutics (VKTX Quick Quote VKTX - Free Report) have risen 29% in the past three months, significantly outperforming the industry’s 2.5% growth. The …

zacks.com

FAQs about VKTX Stock Loses Over $1B in a Month: How to Play … Coupon?

How much has vktx lost in a month?

VKTX Stock Loses Over $1B in a Month: How to Play the Stock? Shares of Viking Therapeutics VKTX have lost nearly 17% in the past month, translating to about $1.2 billion in market value, compared with the industry’s 7.1% decline. ...

What does vktx stand for?

Find the latest Viking Therapeutics, Inc. (VKTX) stock quote, history, news and other vital information to help you with your stock trading and investing. ...

Is Viking Therapeutics (vktx) underperforming the medical industry?

S hares of Viking Therapeutics VKTX have lost nearly 22% in the past six months, significantly underperforming the industry’s 5.3% decline. The stock also underperformed the broader Medical sector and the S&P 500 during this timeframe, as shown in the chart below. VKTX’s shares are currently trading below the 50 and 200-day moving averages. ...

Does Viking Therapeutics (vktx) have a high-potential pipeline?

That said, it's got quite the high-potential pipeline program at present. Viking Therapeutics (VKTX -2.05%) didn't exactly capture investors' hearts in the final month of 2024. ...

Is vk2735 a good stock for weight loss?

Viking is one of the few biotech stocks that have shown immense potential in the obesity space. The company is developing VK2735 as a subcutaneous (SC) injection and an oral pill in mid-stage and early-stage studies, respectively. VK2735 has shown blockbuster potential, demonstrating superior weight reduction capabilities in both clinical studies. ...